Metabolic phenotypes in primary unknown metastatic carcinoma

Area of Science:

• Oncology
• Cancer Metabolism
• Molecular Pathology

Background:

• Primary Unknown Metastatic Carcinoma (PUMC) presents a diagnostic and therapeutic challenge.
• Metabolic reprogramming is a hallmark of cancer, influencing tumor progression and treatment response.
• Evaluating metabolism-related proteins may offer insights into PUMC behavior.

Purpose of the Study:

• To investigate the expression patterns of key metabolism-related proteins in PUMC.
• To correlate protein expression with histologic and clinical subtypes of PUMC.
• To explore the implications of these metabolic profiles for PUMC.

Main Methods:

• Construction of a tissue microarray from 77 PUMC cases.
• Immunohistochemical staining for glycolysis (Glut-1, CA IX, MCT4), glutaminolysis (GLS1, GDH, ASCT2), and mitochondrial (ATP synthase, SDHA, SDHB) proteins.
• Statistical analysis to associate protein expression with clinicopathologic parameters.

Main Results:

• Significant differences in metabolism-related protein expression were observed between histologic subtypes (e.g., higher Glut-1 in squamous cell carcinoma, higher stromal SDHB in adenocarcinoma).
• Metabolic phenotypes correlated with clinical presentation, with distinct patterns observed in nodal versus carcinomatosis types.
• Absence of stromal glutaminolysis was linked to metastasis to lymph nodes, bone, and brain, while its presence correlated with invasion elsewhere.

Conclusions:

• Metabolism-related protein expression (Glut-1, SDHB) in PUMC is subtype-dependent in both tumor and stromal compartments.
• These findings highlight the heterogeneity of PUMC metabolism.
• Understanding these metabolic differences is crucial for tailoring PUMC treatment approaches.